The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcome of elderly patients with classical Hodgkin lymphoma (HL) in British Columbia.
 
Phoebe Tsz Man Cheng
No Relationships to Disclose
 
Diego Villa
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Celgene; Gilead Sciences; Janssen; Lundbeck Canada; Merck; NanoString Technologies; Roche Canada; Seagen
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Celgene; Gilead Sciences; Janssen; Lundbeck Canada; NanoString Technologies; Roche Canada; Seagen
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Acerta Pharma; Janssen; Lundbeck Canada; Roche Canada
 
Alina S. Gerrie
Honoraria - Lundbeck Canada; Seagen
Consulting or Advisory Role - Lundbeck Canada; Seagen
 
Ciara L Freeman
Honoraria - Abbvie; Amgen; Celgene; Janssen; Seagen
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Janssen; Seagen
 
Graham W Slack
No Relationships to Disclose
 
David W. Scott
Consulting or Advisory Role - Celgene; Janssen
Research Funding - Janssen; NanoString Technologies; Roche/Genentech
Patents, Royalties, Other Intellectual Property - As a member of the LLMPP I am potentially a named inventor on a pending patent on the use of gene expression profiling to assign cell-of-origin in diffuse large B-cell lymphoma.; I am a named inventor on a pending patent on the use of gene expression profiling to determine the proliferation signature in mantle cell lymphoma.; Named inventor on a pending patent describing gene expression profiling in prognostication in classical Hodgkin lymphoma.; Named inventor on a pending patent describing using gene expression profiling to identify molecular subtypes of GCB-DLBCL.
 
Joseph M. Connors
Honoraria - Takeda
Research Funding - Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Evaluation of mantle cell lymphoma and methods related thereof (Inst); Methods for selecting and treating lymphoma types (Inst)
 
Laurie Helen Sehn
Honoraria - Abbvie; Acerta Pharma; Amgen; Apobiologix; AstraZeneca; Celgene; Gilead Sciences; Janssen-Ortho; Karyopharm Therapeutics; Kite, a Gilead company; Lundbeck; Merck; morphosys; Roche/Genentech; Seagen; Seagen; Takeda; Takeda; Teva; TG Therapeutics
Consulting or Advisory Role - Abbvie; Acerta Pharma; Amgen; Amgen; apobiologix; AstraZeneca; Celgene; Gilead Sciences; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Lundbeck; Merck; MorphoSys; Roche/Genentech; Seagen; Takeda; Teva; TG therapeutics; TG Therapeutics
Research Funding - Roche/Genentech (Inst)
 
Kerry J. Savage
Honoraria - Bristol-Myers Squibb; Merck; Seagen; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Seagen; Servier; Takeda; Verastem
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Seagen